BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12417276)

  • 21. The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists.
    Tsukahara T
    PPAR Res; 2012; 2012():362361. PubMed ID: 22693486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of adipocyte lipid-binding protein (ALBP) and acyl-coA binding protein (ACBP) in PPAR-mediated transactivation.
    Helledie T; Jørgensen C; Antonius M; Krogsdam AM; Kratchmarova I; Kristiansen K; Mandrup S
    Mol Cell Biochem; 2002 Oct; 239(1-2):157-64. PubMed ID: 12479581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Periodontal Pathogens Modulate Lipid Flux via Fatty Acid Binding Protein 4.
    Kim DJ; Rho JH; Woo BH; Joo JY; Lee JY; Song JM; Lee JH; Park HR
    J Dent Res; 2019 Dec; 98(13):1511-1520. PubMed ID: 31623495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
    Boss M; Kemmerer M; Brüne B; Namgaladze D
    Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adipocyte fatty acid-binding protein expression and lipid accumulation are increased during activation of murine macrophages by toll-like receptor agonists.
    Kazemi MR; McDonald CM; Shigenaga JK; Grunfeld C; Feingold KR
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1220-4. PubMed ID: 15705927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial-derived FABP4 constitutes the majority of basal circulating hormone and regulates lipolysis-driven insulin secretion.
    Inouye KE; Prentice KJ; Lee A; Wang ZB; Dominguez-Gonzalez C; Chen MX; Riveros JK; Burak MF; Lee GY; Hotamışlıgil GS
    JCI Insight; 2023 Jul; 8(14):. PubMed ID: 37279064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells.
    Aragonès G; Saavedra P; Heras M; Cabré A; Girona J; Masana L
    Cardiovasc Diabetol; 2012 Jun; 11():72. PubMed ID: 22709426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effects of FABP4 on Cardiovascular Disease in the Aging Population.
    van der Ark-Vonk EM; Puijk MV; Pasterkamp G; van der Laan SW
    Curr Atheroscler Rep; 2024 May; 26(5):163-175. PubMed ID: 38698167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Network Pharmacology and Transcriptomics Reveal the Mechanism of GuaLouQuMaiWan in Treatment of Type 2 Diabetes and Its Active Small Molecular Compound.
    Feng J; Zhou Y; Liao L; Yu L; Yuan P; Zhang J
    J Diabetes Res; 2022; 2022():2736504. PubMed ID: 36248223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Plasma Oxylipin Signature Provides a Deep Phenotyping of Metabolic Syndrome Complementary to the Clinical Criteria.
    Dalle C; Tournayre J; Mainka M; Basiak-Rasała A; Pétéra M; Lefèvre-Arbogast S; Dalloux-Chioccioli J; Deschasaux-Tanguy M; Lécuyer L; Kesse-Guyot E; Fezeu LK; Hercberg S; Galan P; Samieri C; Zatońska K; Calder PC; Fiil Hjorth M; Astrup A; Mazur A; Bertrand-Michel J; Schebb NH; Szuba A; Touvier M; Newman JW; Gladine C
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome.
    Khasanova AK; Dobrodeeva VS; Shnayder NA; Petrova MM; Pronina EA; Bochanova EN; Lareva NV; Garganeeva NP; Smirnova DA; Nasyrova RF
    Metabolites; 2022 Aug; 12(8):. PubMed ID: 36005598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role and mechanism of the zinc finger protein ZNF580 in foam-cell formation.
    Zhang Z; Qin X; Liu J; Li Y; Chen H; Xie H; Chen J; Li C; Tong Y; Yang M; Zhang M
    Exp Ther Med; 2022 Sep; 24(3):579. PubMed ID: 35949338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the Immunometabolic Role of NF-κB in Adipocytes.
    Griffin MJ
    Immunometabolism; 2022; 4(1):. PubMed ID: 35251704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease.
    Moreno-Vedia J; Girona J; Ibarretxe D; Masana L; Rodríguez-Calvo R
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermedin Inhibits the Ox-LDL-Induced Inflammation in RAW264.7 Cells by Affecting Fatty Acid-Binding Protein 4 Through the PKA Pathway.
    Liu K; Shi R; Wang S; Liu Q; Zhang H; Chen X
    Front Pharmacol; 2021; 12():724777. PubMed ID: 34925001
    [No Abstract]   [Full Text] [Related]  

  • 36. A-FABP in Metabolic Diseases and the Therapeutic Implications: An Update.
    Li HL; Wu X; Xu A; Hoo RL
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidized LDLs as Signaling Molecules.
    Zingg JM; Vlad A; Ricciarelli R
    Antioxidants (Basel); 2021 Jul; 10(8):. PubMed ID: 34439432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirtuin 6 promotes eosinophil differentiation by activating GATA-1 transcription factor.
    Bang IH; Park D; Lee Y; Cho H; Park BH; Bae EJ
    Aging Cell; 2021 Jul; 20(7):e13418. PubMed ID: 34125994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adipocyte Fatty Acid-Binding Protein, Cardiovascular Diseases and Mortality.
    Lee CH; Lui DTW; Lam KSL
    Front Immunol; 2021; 12():589206. PubMed ID: 33815359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An AMPK-dependent, non-canonical p53 pathway plays a key role in adipocyte metabolic reprogramming.
    Wang H; Wan X; Pilch PF; Ellisen LW; Fried SK; Liu L
    Elife; 2020 Dec; 9():. PubMed ID: 33320092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.